Skip to main content
. Author manuscript; available in PMC: 2014 Mar 3.
Published in final edited form as: Gynecol Oncol. 2012 May 15;126(3):351–356. doi: 10.1016/j.ygyno.2012.05.008

TABLE 1.

Intergroup Rhabdomyosarcoma Study Group Clinical Classification System for Rhabdomyosarcoma [8]

Clinical Group Extent of Disease, Resectability, and Margin Status
I A: localized tumor, confined to site of origin, completely resected
B: localized tumor, infiltrating beyond site of origin, completely
resected
II A: localized tumor, gross total resection, but with microscopic
residual disease
B: locally extensive tumor (spread to regional lymph nodes),
completely resected
III A: localized or locally extensive tumor, gross residual disease after
biopsy only
B: localized or locally extensive tumor, gross residual disease after
major resection (≥ 50% debulking)
IV Any size primary tumor, with or without regional lymph node
involvement, with distant metastases, irrespective of surgical
approach to primary tumor